Unprecedented access

Unprecedented access

Author: The BMJ August 28, 2013 Duration: 20:49

John Young, professor of elderly care medicine at Leeds University, gives Mabel Chew tips on carrying out a cognitive assessment of an older person. Also this week, Harlan Krumholz explains to Deborah Cohen how he got Medtronic to agree to independent scrutiny of their data that is “unprecedented in the medical industry”.


Produced by The BMJ, this weekly audio series delves into the pivotal research and urgent clinical debates shaping modern medicine. Each episode moves beyond the published page, bringing together the authors, critics, and practitioners directly involved to dissect a new study or a pressing health question. The conversation is rigorous and nuanced, designed for those who appreciate the complexity behind headlines. You’ll hear unscripted discussion about methodology, implications for practice, and the occasional healthy disagreement that drives science forward. This isn't just a summary of the latest findings; it's a critical appraisal in real time, offering listeners a front-row seat to the evolving discourse that defines evidence-based care. The Medicine and Science from The BMJ podcast serves as an essential audio companion for clinicians, academics, and anyone keen to understand the ‘why’ and ‘how’ behind medical news. It transforms the latest evidence from the journal into an accessible, thought-provoking dialogue, ensuring that busy professionals can stay deeply informed. Tune in for a direct, intelligent, and often surprising take on the science that matters most.
Author: Language: English Episodes: 1000

Medicine and Science from The BMJ
Podcast Episodes
Cancer drug trials used for regulatory approval are at risk of bias [not-audio_url] [/not-audio_url]

Duration: 27:09
Around half of trials that supported new cancer drug approvals in Europe between 2014 and 2016 were judged to be at high risk of bias, in a new study. Huseyin Naci,assistant professor of health policy a the London School…
Brexit - Planning for medicine shortages [not-audio_url] [/not-audio_url]

Duration: 32:16
This week we saw the release of the much awaited Yellowhammer documents from the government, documents which outline some of the risks involved with Britain’s sudden departure from the EU. The documents themselves outlin…
Extending the UK’s sugar tax to snacks [not-audio_url] [/not-audio_url]

Duration: 25:02
In the UK, for just over a year, we've been paying the "Soft Drinks Industry Levy" - a tax on sugary beverages intended to reduce our consumption of free sugars. That was based on taxes that had happened in other countri…
The government is lacking detail over Brexit planning [not-audio_url] [/not-audio_url]

Duration: 36:50
Brexit. Who knows what’s going to happen in the next few weeks, months, years - the uncertainty is high. In the face of that, you’d hope that the government was doing all it could to plan for any eventuality - let alone…
Tackling burnout in The Netherlands [not-audio_url] [/not-audio_url]

Duration: 24:20
We heard a few podcasts ago about burnout - what it is, and why it should be thought of as a systems issue. Now a project in the Netherlands is trying to investigate who it is that is particularly at risk of burnout, and…
Talk Evidence - Tramadol, medical harm, and alexa [not-audio_url] [/not-audio_url]

Duration: 41:28
Welcome back to Talk Evidence - where Helen Macdonald and Carl Heneghan take you through what's happening in the world of Evidence. This month we'll be discussing tramadol being prescripted postoperatively, and a new EBM…
Gottfried Hirnschall is optimistic about ending the HIV epidemic [not-audio_url] [/not-audio_url]

Duration: 47:14
In 2001, Gottfried Hirnschall joined the WHO to work on the global response to HIV/AIDs, 18 years later he just retired as the director of WHO’s department for HIV and Hepatitis. The intervening period, almost half the t…